Dr. Denise Galloway was elected a Fellow of the Academy of the American Association for Cancer Research. Her pioneering work on virus-like particles and the link between HPV and cervical cancer paved the way for the cancer-preventive human papillomavirus vaccine. Galloway’s pioneering investigations of the ways that certain viruses promote cancer allowed her to develop a diagnostic test to predict a recurrence of the deadly skin cancer Merkel cell carcinoma.
“Denise’s research has not only led to a deeper understanding of the molecular biology of HPV infection but also contributed to the development of vaccines that have prevented HPV-linked cancers in thousands of young adults,” said Hutch cancer biologist and AACR Fellow Dr. Robert Eisenman, who nominated Galloway.
AACR Academy Fellows, who undergo a rigorous election process after being nominated by their peers, have made significant and enduring impacts in cancer research. Fellows serve as a global brain trust of top contributors to cancer science and medicine who help advance the mission of the AACR to prevent and cure all cancers through research, education, communication, collaboration, science policy and advocacy, and funding for cancer research, according to the AACR press release.
